Stallergenes Greer, a leader in the field of allergen immunotherapy (AIT), has expanded its presence in the Nordic region in 2024.

Stallergenes Greer is a global company. More than 1,100 employees work from our offices in 21 countries along with a commercial distribution network in 44 countries.

In the Nordic region, our team operates in Denmark, Norway, Sweden and Finland, and we offer solutions for allergen immunotherapy.

Every day, our employees work to achieve our mission: enabling precision medicine to improve the quality of life for people with allergies.